Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tetsuya Hosaka

Showing results (1-10 of 317) with videos related to

Pageof 32
Sort By:
Alimentary Pharmacology & Therapeutics|December 15, 2021
Editorial: can experimental biomarkers be useful for predicting HCC occurrence after sustained viral response in clinical settings?Tetsuya Hosaka
Nihon Rinsho. Japanese Journal of Clinical Medicine|February 6, 2016
[Primary and secondary prevention of HBV-related hepatocellular carcinoma by antiviral treatment]Tetsuya Hosaka
Alimentary Pharmacology & Therapeutics|June 28, 2019
Letter: impact of hepatitis B core-related antigen on the incidence of hepatocellular carcinoma in patients treated with nucleos(t)ide analogues-further clarifications needed. Authors' replyTetsuya Hosaka
Alimentary Pharmacology & Therapeutics|March 15, 2019
Editorial: can hepatitis B core-related antigen be the new biomarker for hepatocellular carcinoma in nucleoside analogue-treated chronic hepatitis B? Author's replyTetsuya Hosaka
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|February 11, 2011
[Efficacy and treatment strategy for drug resistances of nucleos(t)ide analogues for chronic hepatitis B]Tetsuya Hosaka, Fumitaka Suzuki, Hiromitsu Kumada
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|January 23, 2018
[Current issues and management of long-term nucleos(t)ide analogues treatment for chronic hepatitis B]Tetsuya Hosaka, Fumitaka Suzuki, Hiromitsu Kumada
Hepatology (Baltimore, Md.)|October 15, 2013
Reply: To PMID 23213040Tetsuya Hosaka, Fumitaka Suzuki, Hiromitsu Kumada
The American Journal of Gastroenterology|January 5, 2023
Response to Singh et alTai-Chung Tseng, Tetsuya Hosaka, Jia-Horng Kao
AJR. American Journal of Roentgenology|September 24, 2011
Heterogeneous type 4 enhancement of hepatocellular carcinoma on dynamic CT is associated with tumor recurrence after radiofrequency ablationYusuke Kawamura, Kenji Ikeda, Yuya Seko, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 29, 2007
Clinicopathological improvement of non-alcoholic steatohepatitis associated with weight loss during a 14-year follow-up periodTomohiro Nishide, Kenji Ikeda, Yusuke Kawamura, et al.
Pageof 32

Showing results (1-10 of 317) with videos related to

Sort By:
Pageof 32
Alimentary Pharmacology & Therapeutics|December 15, 2021
Editorial: can experimental biomarkers be useful for predicting HCC occurrence after sustained viral response in clinical settings?Tetsuya Hosaka
Nihon Rinsho. Japanese Journal of Clinical Medicine|February 6, 2016
[Primary and secondary prevention of HBV-related hepatocellular carcinoma by antiviral treatment]Tetsuya Hosaka
Alimentary Pharmacology & Therapeutics|June 28, 2019
Letter: impact of hepatitis B core-related antigen on the incidence of hepatocellular carcinoma in patients treated with nucleos(t)ide analogues-further clarifications needed. Authors' replyTetsuya Hosaka
Alimentary Pharmacology & Therapeutics|March 15, 2019
Editorial: can hepatitis B core-related antigen be the new biomarker for hepatocellular carcinoma in nucleoside analogue-treated chronic hepatitis B? Author's replyTetsuya Hosaka
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|February 11, 2011
[Efficacy and treatment strategy for drug resistances of nucleos(t)ide analogues for chronic hepatitis B]Tetsuya Hosaka, Fumitaka Suzuki, Hiromitsu Kumada
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|January 23, 2018
[Current issues and management of long-term nucleos(t)ide analogues treatment for chronic hepatitis B]Tetsuya Hosaka, Fumitaka Suzuki, Hiromitsu Kumada
Hepatology (Baltimore, Md.)|October 15, 2013
Reply: To PMID 23213040Tetsuya Hosaka, Fumitaka Suzuki, Hiromitsu Kumada
The American Journal of Gastroenterology|January 5, 2023
Response to Singh et alTai-Chung Tseng, Tetsuya Hosaka, Jia-Horng Kao
AJR. American Journal of Roentgenology|September 24, 2011
Heterogeneous type 4 enhancement of hepatocellular carcinoma on dynamic CT is associated with tumor recurrence after radiofrequency ablationYusuke Kawamura, Kenji Ikeda, Yuya Seko, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 29, 2007
Clinicopathological improvement of non-alcoholic steatohepatitis associated with weight loss during a 14-year follow-up periodTomohiro Nishide, Kenji Ikeda, Yusuke Kawamura, et al.
Pageof 32